News

On September 29, 2025, Hangzhou Yaoaccelerated Medical Isotope Technology Co., Ltd. (hereinafter referred to as "Yaoaccelerated"), a hard...

We recently successfully obtained an order of retatrutide products from a German client, further expanding our business footprint in the European m...

We recently established in-depth cooperation with a valued UAE customer and successfully secured a tropicamide order, a testament to the trust forg...

We recently reconnected with our long-term Brazilian customer and secured a Tirzepatide order, reaffirming the profound trust built between us over...

We recently secured a repeat order from a U.S. customer, who placed an order for multiple specifications of our core products including Retatrutide...

We recently secured a trial order for Red Phosphorus powder with a German customer, who plans to transport the product to Poland. This cooperation ...

We provide GLP-1 peptide , please refer to the following website for detailed specifications and product information. Product: https://www.bloomtec...

Xinlitai releases Phase I research data on SiRNA therapy for hypertension On March 31, 2026, Xinli Tai announced that it had recently unveiled the ...

According to the national legal holiday regulations and the actual situation of our company, the May Day holiday arrangement is announced as follow...

In the global chemical trade landscape, every cooperation with new customers is like an adventure full of unknowns. Bloom Tech, as a company deeply...

On March 18, 2026, Zhongxin Biotechnology announced that the US Food and Drug Administration (FDA) has approved its clinical trial (IND) applicatio...

On March 16, 2026, Structure Therapeutics announced that Alenigliffon, which is used to treat patients with obesity/overweight and at least one wei...